The pathogenesis of acute myocardial infarction is known to be mediated by systemic,
intraplaque and myocardial inflammatory processes. Among different immune cell subsets …

Abstract Aims The COLchicine Cardiovascular Outcomes Trial (COLCOT) demonstrated the
benefits of targeting inflammation after myocardial infarction (MI). We aimed to determine …

After acute myocardial infarction, ventricular remodeling is characterized by changes at the
molecular, structural, geometrical and functional level that determine progression to heart …

Background—Inflammatory processes have been identified as key mediators of the
deleterious effects of ischemia/reperfusion in ST-segment–elevation myocardial infarction …

Background Neutrophil lymphocyte ratio (NLR) has been shown to predict cardiovascular
events in several studies. We sought to study if NLR predicts coronary heart disease (CHD) …

Objectives: The aim of this study was to investigate the clinical significance of native T1
values in remote myocardium in survivors of acute ST-segment elevation myocardial …

The neutrophil–lymphocyte ratio (NLR) is an inflammatory marker of major adverse cardiac
events (MACEs) in both acute coronary syndromes and stable coronary artery disease. The …

The neutrophil to lymphocyte ratio (NLR), an inflammatory biomarker, may be of predictive
and prognostic value for cardiovascular (CV) events. We evaluated the relationship of NLR …

Neutrophils are polymorphonuclear leucocytes that are distinguished and named by the
special shape of their multi-lobed nucleus. They function as an early defence against …

Background In patients with acute ST-elevation myocardial infarction (STEMI), elevated
concentrations of inflammatory markers are correlated with worse clinical outcome. The aim …